Big Gain For CinCor Pharma Inc.
Mon, Aug 08, 2022 at 07:20 PM
CinCor Pharma Inc. (CINC:NASDAQ) jumped higher at $35, representing a gain of 49.3%. On Mon, Aug 08, 2022, CINC:NASDAQ touched a New 2-Week High of $35. The stock appeared on our News Catalysts scanner on Mon, Aug 08, 2022 at 07:15 PM in the 'PUBLIC OFFERING' category. From Mon, Jul 25, 2022, the stock recorded 60.00% Up Days and 54.55% Green Days
About CinCor Pharma Inc. (CINC:NASDAQ)
CinCor Pharma Inc is a clinical-stage biopharmaceutical company focused on developing its lead clinical candidate, CIN-107, for the treatment of hypertension and other cardio-renal diseases.
Top 10 Gainers:
- Helbiz Inc. (HLBZ:NASDAQ), 114.64%
- Zhong Yang Financial Group Limited (TOP:NASDAQ), 102.66%
- Karuna Therapeutics, Inc. (KRTX:NASDAQ), 71.84%
- Senmiao Technology Limited (AIHS:NASDAQ), 68.14%
- Bonso Electronics International Inc. (BNSO:NASDAQ), 64.85%
- Heart Test Laboratories, Inc. (HSCS:NASDAQ), 55.66%
- CinCor Pharma Inc. (CINC:NASDAQ), 49.25%
- SOS Limited American Depositary Shares (SOS:NYSE), 42.8%
- Surgalign Holdings Inc. (SRGA:NASDAQ), 42.25%
- Intelligent Living Application Group Inc. (ILAG:NASDAQ), 40.83%